107 results
8-K
EX-4.1
ALRN
Aileron Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
5:25pm
Shares shall be made without charge to the Holder for any issue or transfer tax or other incidental expense in respect of the issuance of such Warrant … and the Company may require, as a condition thereto, the payment of a sum sufficient to reimburse it for any transfer tax incidental thereto. The Company
8-K
EX-1.1
ALRN
Aileron Therapeutics Inc
1 May 24
Entry into a Material Definitive Agreement
5:25pm
are listed or designated.
(dd) Tax Status. Except for matters that would not, individually or in the aggregate, have or reasonably be expected … and all foreign income and franchise tax returns, reports and declarations required by any jurisdiction to which it is subject, (ii) has paid all taxes
424B5
ALRN
Aileron Therapeutics Inc
1 May 24
Prospectus supplement for primary offering
5:24pm
USE OF PROCEEDS
S-13
DIVIDEND POLICY
S-14
DILUTION
S-15
DESCRIPTION OF SECURITIES WE ARE OFFERING
S-17
MATERIAL U.S. TAX CONSIDERATIONS FOR NON-U.S …
MATERIAL U.S. TAX CONSIDERATIONS FOR HOLDERS OF COMMON STOCK OR WARRANTS
The following is a discussion of the material U.S. federal income and estate
S-8
EX-99.1
aghutlrf wbwu9ca
29 Jan 24
Registration of securities for employees
4:15pm
8-K
EX-10.4
lu9utgwai 316q2
25 Jan 24
Other Events
7:00am
8-K
EX-10.5
l3oi6t7bfu2ls imu8
25 Jan 24
Other Events
7:00am
8-K
EX-10.1
upr7qhpbp
25 Jan 24
Other Events
7:00am
8-K
jw03x8
25 Jan 24
Other Events
7:00am
8-K
EX-10.2
kygolwlpr87yljbxr kr
25 Jan 24
Other Events
7:00am
8-K
EX-10.3
uoxj5bpvv
25 Jan 24
Other Events
7:00am
8-K/A
EX-99.1
rj7h2eaizzfkh 23
11 Jan 24
Index to Consolidated Financial Statements
4:18pm
8-K/A
EX-99.2
4bzk0zok4 y4dhyu
11 Jan 24
Index to Consolidated Financial Statements
4:18pm